Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20174617rdf:typepubmed:Citationlld:pubmed
pubmed-article:20174617lifeskim:mentionsumls-concept:C0085243lld:lifeskim
pubmed-article:20174617lifeskim:mentionsumls-concept:C0052441lld:lifeskim
pubmed-article:20174617lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:20174617lifeskim:mentionsumls-concept:C0229783lld:lifeskim
pubmed-article:20174617lifeskim:mentionsumls-concept:C0039635lld:lifeskim
pubmed-article:20174617lifeskim:mentionsumls-concept:C0011847lld:lifeskim
pubmed-article:20174617lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:20174617lifeskim:mentionsumls-concept:C1416467lld:lifeskim
pubmed-article:20174617lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:20174617lifeskim:mentionsumls-concept:C1292733lld:lifeskim
pubmed-article:20174617pubmed:issue4lld:pubmed
pubmed-article:20174617pubmed:dateCreated2010-7-23lld:pubmed
pubmed-article:20174617pubmed:abstractTextThe ligand-activated transcription factor, aryl hydrocarbon receptor (AHR), is a novel inducer of adaptive Tregs. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD), the most potent AHR ligand, induces adaptive CD4+CD25+ Tregs during an acute graft-versus-host (GvH) response and prevents the generation of allospecific cytotoxic T lymphocytes. TCDD also suppresses the induction of experimental autoimmune encephalitis in association with an expanded population of Foxp3+ Tregs. In this study, we show that chronic treatment of NOD mice with TCDD potently suppresses the development of autoimmune Type 1 diabetes in parallel with greatly reduced pancreatic islet insulitis and an expanded population of CD4+CD25+Foxp3+ cells in the pancreatic lymph nodes. When treatment with TCDD was terminated after 15 weeks (23 weeks of age), mice developed diabetes over the next 8 weeks in association with lower numbers of Tregs and decreased activation of AHR. Analysis of the expression levels of several genes associated with inflammation, T-cell activation and/or Treg function in pancreatic lymph node cells failed to reveal any differences associated with TCDD treatment. Taken together, the data suggest that AHR activation by TCDD-like ligands may represent a novel avenue for treatment of immune-mediated diseases.lld:pubmed
pubmed-article:20174617pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:languageenglld:pubmed
pubmed-article:20174617pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:citationSubsetIMlld:pubmed
pubmed-article:20174617pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20174617pubmed:statusMEDLINElld:pubmed
pubmed-article:20174617pubmed:monthJullld:pubmed
pubmed-article:20174617pubmed:issn1750-7448lld:pubmed
pubmed-article:20174617pubmed:authorpubmed-author:Nemblld:pubmed
pubmed-article:20174617pubmed:authorpubmed-author:KerkvlietNanc...lld:pubmed
pubmed-article:20174617pubmed:authorpubmed-author:WongCarmen...lld:pubmed
pubmed-article:20174617pubmed:authorpubmed-author:MourichDan...lld:pubmed
pubmed-article:20174617pubmed:authorpubmed-author:SteppanLinda...lld:pubmed
pubmed-article:20174617pubmed:authorpubmed-author:VorachekWilli...lld:pubmed
pubmed-article:20174617pubmed:authorpubmed-author:OdaShannonSlld:pubmed
pubmed-article:20174617pubmed:authorpubmed-author:FarrerDavidDlld:pubmed
pubmed-article:20174617pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20174617pubmed:volume1lld:pubmed
pubmed-article:20174617pubmed:ownerNLMlld:pubmed
pubmed-article:20174617pubmed:authorsCompleteYlld:pubmed
pubmed-article:20174617pubmed:pagination539-47lld:pubmed
pubmed-article:20174617pubmed:dateRevised2011-9-26lld:pubmed
pubmed-article:20174617pubmed:meshHeadingpubmed-meshheading:20174617...lld:pubmed
pubmed-article:20174617pubmed:meshHeadingpubmed-meshheading:20174617...lld:pubmed
pubmed-article:20174617pubmed:meshHeadingpubmed-meshheading:20174617...lld:pubmed
pubmed-article:20174617pubmed:meshHeadingpubmed-meshheading:20174617...lld:pubmed
pubmed-article:20174617pubmed:meshHeadingpubmed-meshheading:20174617...lld:pubmed
pubmed-article:20174617pubmed:meshHeadingpubmed-meshheading:20174617...lld:pubmed
pubmed-article:20174617pubmed:meshHeadingpubmed-meshheading:20174617...lld:pubmed
pubmed-article:20174617pubmed:meshHeadingpubmed-meshheading:20174617...lld:pubmed
pubmed-article:20174617pubmed:meshHeadingpubmed-meshheading:20174617...lld:pubmed
pubmed-article:20174617pubmed:meshHeadingpubmed-meshheading:20174617...lld:pubmed
pubmed-article:20174617pubmed:meshHeadingpubmed-meshheading:20174617...lld:pubmed
pubmed-article:20174617pubmed:meshHeadingpubmed-meshheading:20174617...lld:pubmed
pubmed-article:20174617pubmed:meshHeadingpubmed-meshheading:20174617...lld:pubmed
pubmed-article:20174617pubmed:meshHeadingpubmed-meshheading:20174617...lld:pubmed
pubmed-article:20174617pubmed:meshHeadingpubmed-meshheading:20174617...lld:pubmed
pubmed-article:20174617pubmed:year2009lld:pubmed
pubmed-article:20174617pubmed:articleTitleActivation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes.lld:pubmed
pubmed-article:20174617pubmed:affiliationOregon State University, Department of Microbiology, Corvallis, OR 97331, USA.lld:pubmed
pubmed-article:20174617pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20174617pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:11622entrezgene:pubmedpubmed-article:20174617lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20174617lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20174617lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20174617lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20174617lld:pubmed
More...